Bifidobacterium infantis modulates intestinal microecology to inhibit the spread of antimicrobial resistance.

2025-11-18
mSystems 10(11)

PubMed: 41171056
DOI: 10.1128/msystems.00728-25

Study Design

Population: mice
Methods: supplementing with Bifidobacterium infantis 15697; using a mouse infection model

Rigorous Journal

Early administration of antibiotics in children may heighten the susceptibility to multidrug-resistant bacterial infections. While probiotics are commonly employed for bacterial infection management, their nuanced advantages, particularly in curtailing the spread of antimicrobial resistance (AMR), remain unclear. This study investigated the role and mechanisms of Bifidobacterium infantis in inhibiting the spread of antibiotic resistance genes (ARGs) in the gut. We found that supplementing with B. infantis 15697 significantly enhanced the synthesis of bile acids in mouse feces, particularly tauroursodeoxycholic acid (TUDCA) and taurocholic acid (TCA). Concurrently, the abundance of potential probiotics such as Parabacteroides goldsteinii in the gut significantly increased. Using a mouse infection model, we discovered that B. infantis supplementation inhibited the colonization of antibiotic-resistant Escherichia coli in the gut and the events of horizontal gene transfer, thereby reducing the spread of ARGs. Further analysis revealed that TUDCA and TCA, through their interaction with the OmpC protein, decreased the biofilm formation capability and cell membrane permeability of antibiotic-resistant bacteria, inhibiting the horizontal spread of ARGs. These findings reveal the important role of B. infantis in regulating the gut microbiota and inhibiting the spread of ARGs, providing a theoretical basis for developing new probiotic intervention strategies. This could help reduce the global spread of AMR and protect human health.

Importance

The global spread of antimicrobial resistance (AMR) has become a significant threat to public health, particularly in children, where the overuse of antibiotics leads to gut microbiota imbalance and increases the risk of horizontal transfer of antibiotic resistance genes (ARGs). This study supplemented mice with Bifidobacterium infantis 15697, which significantly enhanced the synthesis of bile acids, especially tauroursodeoxycholic acid and taurocholic acid, while promoting the growth of probiotics and inhibiting the colonization of antibiotic-resistant bacteria and the spread of ARGs. This finding not only reveals the important role of B. infantis in regulating the gut microbiota and inhibiting the spread of ARGs but also provides a theoretical basis for developing new probiotic intervention strategies. By modulating the gut microbiota and bile acid metabolism, B. infantis has the potential to become an effective means of reducing the spread of AMR. This is of great significance for protecting the gut health of children and adults, reducing the risk of resistant infections, and also provides scientific evidence for the formulation of global public health policies.

Research Insights

Supplement	Dose	Health Outcome	Effect Type	Effect Size	Source
Bifidobacterium infantis	—	Improved Gut Microbiota Balance	Beneficial	Moderate	View source supplementing with B. infantis 15697 significantly enhanced the synthesis of bile acids in mouse feces... Concurrently, the abundance of potential probiotics such as Parabacteroides goldsteinii in the gut significantly increased.
Bifidobacterium infantis	—	No Reduction in Antibiotic-Resistant Organism Colonization	Beneficial	Moderate	View source We discovered that B. infantis supplementation inhibited the colonization of antibiotic-resistant Escherichia coli in the gut